Study Information

Alliance Study ID: N0574

NCT Study ID (ClinicalTrials.gov): NCT00377156

Alliance Committee: Neuro-Oncology

Disease or Cancer Type: Brain / Central Nervous System Cancer

Alliance Study Chair: Paul D. Brown, MD

Status: COMPLETED


Study Description

RATIONALE: Stereotactic radiation therapy can send x-rays directly to the tumor and cause less damage to normal tissue. Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether stereotactic radiation therapy is more effective with or without whole-brain radiation therapy in treating patients with brain metastases.

PURPOSE: This randomized phase III trial is studying stereotactic radiation therapy and whole-brain radiation therapy to see how well they work compared with stereotactic radiation therapy alone in treating patients with brain metastases.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials